Francisco Mazzei | Project Oversight Director, Vaccines
PPD, the Clinical Research business of Thermo Fisher Scientific

Francisco Mazzei, Project Oversight Director, Vaccines, PPD, the Clinical Research business of Thermo Fisher Scientific

Mr. Mazzei has over 25 years of experience in clinical research within the pharmaceutical life sciences industry. He joined PPD in February 2005 and currently serves as project oversight director for vaccines, managing a portfolio of Phase I-III studies to ensure delivery, compliance, and efficiency in close partnership with sponsors. Previously, Mr. Mazzei led clinical supply chain operations as an oversight director in numerous clinical development programs across several therapeutic indications and regions. He has also served as a subject matter expert in good clinical logistics practices, cold chain management, labeling, trade compliance and other business optimization processes, including the use of tracking technologies for various applications within and outside clinical supply cycle.

Prior to joining PPD, Mr. Mazzei worked for eight years in different roles within the BioPharma industry and consultancy, and previously as a pharmacist in the retail industry and academia. He earned his professional degree in pharmacy & chemistry at the University of Concepcion, Chile, and an MBA in international business at Gabriela Mistral University, Chile.

Appearances:



Day 2 - Wednesday 15th October @ 12:00

Clinical Supplies Logistics for Global Mega Vaccine Trials

last published: 07/May/25 13:55 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2025

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com

 

Otto Squire
Otto.Squire@terrapinn.com

 

TO SPEAK


Anna Hindley-Skelt
Anna.Hindley-Skelt@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.